A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
PHASE3CompletedINTERVENTIONAL
Enrollment
381
Participants
Timeline
Start Date
April 30, 2001
Study Completion Date
December 31, 2006
Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00246285 - A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia | Biotech Hunter | Biotech Hunter